Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

ImmunoGen's antibody humanization technology reported to be superior to conventional methods

Oct. 25, 1996

Megabios in vivo gene delivery systems available for licensing

Oct. 25, 1996

Pharmacopeia receives patent coverage for drug discovery technology

Oct. 25, 1996

P&U reports compounds for improving drug bioavailability

Oct. 25, 1996

Funding for Genetronics' electroporation delivery technology

Oct. 18, 1996

Regeneron-Pharmacopeia drug discovery collaboration

Oct. 18, 1996

Peptidomimetic compounds disclosed by University of Pennsylvania

Oct. 18, 1996

Palatin receives grants for the development of peptide-based therapeutics and diagnostics

Oct. 11, 1996

Geron licenses technologies for use in the treatment of age-related diseases

Oct. 11, 1996

Patent coverage for new gene expression system

Oct. 11, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...